drugset / Trial / NCT00669851

Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study

NCT00669851

Phase 3 Completed 39 enrolled Acusphere
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

This study evaluated and optimized settings for, and evaluated the performance of, AI-700-enhanced echocardiographic imaging on several ultrasound imaging platforms, as well as collected additional safety data for AI-700 in healthy volunteers and stable cardiac patients.

Timeline

Start
2006-11
Primary completion
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Perflubutane Diagnostic / imaging agent 0.04 unknown